S.Biomedics Co., Ltd. (KOSDAQ:304360)

S.Biomedics Statistics

Total Valuation

S.Biomedics has a market cap or net worth of KRW 347.40 billion. The enterprise value is 353.00 billion.

Market Cap	347.40B
Enterprise Value	353.00B

Important Dates

The last earnings date was Monday, April 6, 2026.

Earnings Date	Apr 6, 2026
Ex-Dividend Date	n/a

Share Statistics

S.Biomedics has 12.39 million shares outstanding. The number of shares has increased by 3.22% in one year.

Current Share Class	12.39M
Shares Outstanding	12.39M
Shares Change (YoY)	+3.22%
Shares Change (QoQ)	+1.24%
Owned by Insiders (%)	21.64%
Owned by Institutions (%)	n/a
Float	9.13M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	20.99
PB Ratio	20.77
P/TBV Ratio	41.61
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-43.46
EV / Sales	21.33
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-41.12

Financial Position

The company has a current ratio of 1.61, with a Debt / Equity ratio of 0.73.

Current Ratio	1.61
Quick Ratio	1.33
Debt / Equity	0.73
Debt / EBITDA	n/a
Debt / FCF	-1.42
Interest Coverage	-5.75

Financial Efficiency

Return on equity (ROE) is -40.30% and return on invested capital (ROIC) is -15.80%.

Return on Equity (ROE)	-40.30%
Return on Assets (ROA)	-12.15%
Return on Invested Capital (ROIC)	-15.80%
Return on Capital Employed (ROCE)	-28.87%
Weighted Average Cost of Capital (WACC)	12.58%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.39
Inventory Turnover	4.26

Taxes

In the past 12 months, S.Biomedics has paid 250.51 million in taxes.

Income Tax	250.51M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +22.89% in the last 52 weeks. The beta is 1.53, so S.Biomedics's price volatility has been higher than the market average.

Beta (5Y)	1.53
52-Week Price Change	+22.89%
50-Day Moving Average	33,362.00
200-Day Moving Average	27,128.95
Relative Strength Index (RSI)	41.51
Average Volume (20 Days)	88,295

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, S.Biomedics had revenue of KRW 16.55 billion and -8.12 billion in losses. Loss per share was -684.07.

Revenue	16.55B
Gross Profit	7.55B
Operating Income	-8.34B
Pretax Income	-6.81B
Net Income	-8.12B
EBITDA	-6.30B
EBIT	-8.34B
Loss Per Share	-684.07

Balance Sheet

The company has 14.66 billion in cash and 12.21 billion in debt, with a net cash position of 2.46 billion or 198.31 per share.

Cash & Cash Equivalents	14.66B
Total Debt	12.21B
Net Cash	2.46B
Net Cash Per Share	198.31
Equity (Book Value)	16.73B
Book Value Per Share	709.84
Working Capital	7.51B

Cash Flow

In the last 12 months, operating cash flow was -3.98 billion and capital expenditures -4.60 billion, giving a free cash flow of -8.58 billion.

Operating Cash Flow	-3.98B
Capital Expenditures	-4.60B
Depreciation & Amortization	2.04B
Net Borrowing	-1.48B
Free Cash Flow	-8.58B
FCF Per Share	-693.12

Margins

Gross margin is 45.61%, with operating and profit margins of -50.42% and -49.08%.

Gross Margin	45.61%
Operating Margin	-50.42%
Pretax Margin	-41.15%
Profit Margin	-49.08%
EBITDA Margin	-38.08%
EBIT Margin	-50.42%
FCF Margin	n/a

Dividends & Yields

S.Biomedics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.22%
Shareholder Yield	-3.22%
Earnings Yield	-2.34%
FCF Yield	-2.47%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

S.Biomedics has an Altman Z-Score of 3.83 and a Piotroski F-Score of 3.

Altman Z-Score	3.83
Piotroski F-Score	3